Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc.. Optical Coherence Tomography (OCT) for plaque characterization and stent implantation. Lansdale: HAYES, Inc.. Directory Publication. 2016 Authors' conclusions Purpose of Technology: Optical coherence tomography (OCT) relies on detection of reflected infrared light to generate a highly detailed, magnified view of a thin layer of tissue. This technology has been adapted to percutaneous catheters and is being used to examine features of intracoronary plaques and stents that may increase the risk of subsequent adverse events such as clot formation or blockage of the affected coronary artery.
Relevant Questions: Does use of OCT accurately predict complications related to PCI with stenting and adverse cardiac events in patients with CAD? Does OCT provide information that improves the care of patients who have CAD? Is OCT safe? Which patients might be suitable candidates for OCT? Indexing Status Subject indexing assigned by CRD MeSH Drug-Eluting Stents; Humans; Plaque, Atherosclerotic; Tomography, Optical Coherence Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32016000981 Date abstract record published 31/08/2016 |